Lipid Management – Rapid Uptake Product

Improving outcomes for patients with CVD is a clinical priority in NHS Long-Term Plan. To support delivery, NHS England Lipid Management Rapid Uptake Product Working Group have developed a NICE-endorsed clinical pathway along with a companion document for statin intolerance.

SPS commentary:

A two page summary is provided of national guidance for lipid management for primary and secondary prevention of CVD based on NICE 2016 (TA385, TA393, and TA394), NICE. 2014 (CG181), NICE. 2008 (CG71) and NICE 2021 (TA694).

The Statin intolerance pathway includes an algorithm for managing a person at high CVD risk who reports potential intolerance, based on NICE guidance CG181, CG71, TA385, TA393/394, and QS100.

NHS England

Resource links:

Summary of national guidance for lipid management

Statin intolerance pathway.